ABSTRACT
BACKGROUND: The SEUSA program, the Donation and Transplantation Institute foundation consultancy program, was implemented in Trinidad and Tobago (T&T) in 2010 with the support of the National Organ Transplant Unit (NOTU) and the Ministry of Health of T&T. METHODS: The SEUSA program included (1) diagnosis of the current situation using the ODDS (Organ Donation Diagnostic Surveys); (2) creation of a human resources structure through Transplant Procurement Management (TPM); (3) detection of all brain and cardiac deaths in the hospitals implementing the DAS (Decease Alert System); (4) in-hospital awareness based on the EODS (Essentials in Organ Donation); and (5) external hospital audits. Additionally continued monitoring is performed. RESULTS: Thus far, thanks to implementation of the SEUSA program in Trinidad and Tobago 175, healthcare professionals have been exposed to training programs in the organ donation field. The Living Kidney Program was reinforced and the structure of the Deceased Donation (DD) network was defined. Since 2010, 485 potential organ donors have been detected, and 9 have become actual organ donors; 74 patients have received a kidney transplant (59 from living and 15 from deceased donors). CONCLUSIONS: This project results demonstrate that the application of the SEUSA program is an efficient methodology to develop DD programs that increase and consolidate transplant programs in the Caribbean region.
Subject(s)
Program Development , Tissue and Organ Procurement/organization & administration , Humans , Organ Transplantation/statistics & numerical data , Surveys and Questionnaires , Tissue Donors/statistics & numerical data , Trinidad and TobagoABSTRACT
B-cell differentiation is accompanied by a dramatic increase in cytoplasmic accumulation and stability of the IgM heavy chain (mu) secretory mRNA. Despite considerable effort, the mechanism is unknown. We have identified three short motifs upstream of the secretory poly(A) site, which, when mutated in the mu heavy chain gene, significantly increase the accumulation of the secretory form of poly(A)(+) mRNA relative to the membrane form and regulate the expression of the secretory poly(A) site in a developmental manner. We show that these motifs bind U1A and inhibit polyadenylation in vitro and in vivo. Overexpression of U1A in vivo results in the selective inhibition of the secretory form. Thus, this novel mechanism selectively controls post-cleavage expression of the mu secretory mRNA. We present evidence that this mechanism is used to regulate alternative expression of other genes.
Subject(s)
Cell Nucleus/metabolism , Gene Expression Regulation , Immunoglobulin M/biosynthesis , Immunoglobulin M/genetics , Poly A/metabolism , RNA, Messenger/metabolism , Amino Acid Motifs , Animals , B-Lymphocytes/cytology , Base Sequence , Binding Sites , Cattle , Cell Differentiation , DNA Mutational Analysis , Dose-Response Relationship, Drug , Escherichia coli/metabolism , HeLa Cells , Humans , Models, Genetic , Molecular Sequence Data , Mutation , Plasmids/metabolism , Protein Binding , Recombinant Proteins/metabolism , Ribonucleases/metabolism , TransfectionABSTRACT
Although the primary function of U1 snRNA is to define the 5' donor site of an intron, it can also block the accumulation of a specific RNA transcript when it binds to a donor sequence within its terminal exon. This work was initiated to investigate if this property of U1 snRNA could be exploited as an effective method for inactivating any target gene. The initial 10-bp segment of U1 snRNA, which is complementary to the 5' donor sequence, was modified to recognize various target mRNAs (chloramphenicol acetyltransferase [CAT], beta-galactosidase, or green fluorescent protein [GFP]). Transient cotransfection of reporter genes and appropriate U1 antitarget vectors resulted in >90% reduction of transgene expression. Numerous sites within the CAT transcript were suitable for targeting. The inhibitory effect of the U1 antitarget vector is directly related to the hybrid formed between the U1 vector and target transcripts and is dependent on an intact 70,000-molecular-weight binding domain within the U1 gene. The effect is long lasting when the target (CAT or GFP) and U1 antitarget construct are inserted into fibroblasts by stable transfection. Clonal cell lines derived from stable transfection with a pOB4GFP target construct and subsequently stably transfected with the U1 anti-GFP construct were selected. The degree to which GFP fluorescence was inhibited by U1 anti-GFP in the various clonal cell lines was assessed by fluorescence-activated cell sorter analysis. RNA analysis demonstrated reduction of the GFP mRNA in the nuclear and cytoplasmic compartment and proper 3' cleavage of the GFP residual transcript. An RNase protection strategy demonstrated that the transfected U1 antitarget RNA level varied between 1 to 8% of the endogenous U1 snRNA level. U1 antitarget vectors were demonstrated to have potential as effective inhibitors of gene expression in intact cells.
Subject(s)
Gene Expression , Gene Targeting/methods , RNA, Small Nuclear/genetics , RNA, Small Nuclear/metabolism , 3T3 Cells , Animals , Base Sequence , Chloramphenicol O-Acetyltransferase/genetics , DNA/genetics , Genes, Reporter , Green Fluorescent Proteins , Luminescent Proteins/genetics , Mice , Transfection , beta-Galactosidase/geneticsABSTRACT
OBJECTIVE: To evaluate the impact of a high school education program to promote organ donation awareness. The primary outcomes were intention to discuss organ donation with family or friends and actual discussion behavior. DESIGN: Longitudinal, observational study. METHODS: 665 high school students filled out evaluations at the beginning and at the end of a 1-hour education program. One month later, the students were asked to report whether they had discussed donation. RESULTS: After the program, knowledge and attitude scores and the proportion of students who intended to discuss donation increased (P < .05). At 1-month follow-up, 48% of students reported actual discussion. Intention has a strong, positive relationship with discussion behavior (odds ratio, 8.27; 95% CI, 3.18-21.51). Ethnicity, sex, and attitude of the students were also predictors of donation discussion behavior. CONCLUSIONS: This program appears to be effective in prompting discussion of organ donation among high school students.
Subject(s)
Health Knowledge, Attitudes, Practice , Students/psychology , Tissue and Organ Procurement/organization & administration , Adolescent , Female , Humans , Logistic Models , Longitudinal Studies , Male , Minnesota , Program Evaluation , Surveys and QuestionnairesABSTRACT
Four Candida albicans isolates and six non-albicans Candida isolates were evaluated by time-kill methods to characterize the relationship between nystatin concentrations, the rate and extent of fungicidal activity, and the postantifungal effect (PAFE). Against Candida species, nystatin exhibits concentration-dependent fungicidal activity and a pronounced PAFE.
Subject(s)
Antifungal Agents/pharmacology , Candida/drug effects , Nystatin/pharmacology , Candida albicans/drug effects , Candidiasis/microbiology , Colony Count, Microbial , Microbial Sensitivity TestsABSTRACT
The status of the poly(A) tail at the 3'-end of mRNAs controls the expression of numerous genes in response to developmental and extracellular signals. Poly(A) tail regulation requires cooperative binding of two human U1A proteins to an RNA regulatory region called the polyadenylation inhibition element (PIE). When bound to PIE RNA, U1A proteins also bind to the enzyme responsible for formation of the mature 3'-end of most eukaryotic mRNAs, poly(A) polymerase (PAP). The NMR structure of the 38 kDa complex formed between two U1A molecules and PIE RNA shows that binding cooperativity depends on helix C located at the end of the RNA-binding domain and just adjacent to the PAP-interacting domain of U1A. Since helix C undergoes a conformational change upon RNA binding, the structure shows that binding cooperativity and interactions with PAP occur only when U1A is bound to its cognate RNA. This mechanism ensures that the activity of PAP enzyme, which is essential to the cell, is only down regulated when U1A is bound to the U1A mRNA.
Subject(s)
Poly A/metabolism , RNA, Messenger/metabolism , RNA-Binding Proteins/metabolism , Regulatory Sequences, Nucleic Acid/genetics , Ribonucleoprotein, U1 Small Nuclear/chemistry , Ribonucleoprotein, U1 Small Nuclear/metabolism , 3' Untranslated Regions/chemistry , 3' Untranslated Regions/genetics , 3' Untranslated Regions/metabolism , Allosteric Regulation , Amino Acid Sequence , Base Sequence , Binding Sites , Humans , Models, Molecular , Molecular Sequence Data , Molecular Weight , Nuclear Magnetic Resonance, Biomolecular , Nucleic Acid Conformation , Polynucleotide Adenylyltransferase/antagonists & inhibitors , Polynucleotide Adenylyltransferase/metabolism , Protein Binding , Protein Structure, Secondary , RNA Processing, Post-Transcriptional/genetics , RNA, Messenger/chemistry , RNA, Messenger/genetics , RNA-Binding Proteins/chemistry , Structure-Activity Relationship , Substrate SpecificityABSTRACT
The 3' ends of most eukaryotic pre-mRNAs are generated by 3' endonucleolytic cleavage and subsequent polyadenylation. 3'-end formation can be influenced positively or negatively by various factors. In particular, U1 snRNP acts as an inhibitor when bound to a 5' splice site located either upstream of the 3'-end formation signals of bovine papilloma virus (BPV) late transcripts or downstream of the 3'-end processing signals in the 5' LTR of the HIV-1 provirus. Previous work showed that in BPV it is not the first step, 3' cleavage, that is affected by U1 snRNP, but rather the second step, polyadenylation, that is inhibited. Since in HIV-1 the biological requirement is to produce transcripts that read through the 5' LTR cleavage site rather than being cleaved there, this mechanism seemed unlikely to apply. The obvious difference between the two examples was the relative orientation of the 3'-end formation signals and the U1 snRNP-binding site. In vitro assays were therefore used to assess the effect of U1 snRNP bound at various locations relative to a cleavage/polyadenylation site on the 3' cleavage reaction. U1 snRNP was found to inhibit cleavage when bound to a 5' splice site downstream of the cleavage/polyadenylation site, as in the HIV-1 LTR. U1 snRNP binding at this location was shown not to affect the recruitment of multiple cleavage/polyadenylation factors to the cleavage substrate, indicating that inhibition is unlikely to be due to steric hindrance. Interactions between U1A, U1 70K, and poly(A) polymerase, which mediate the effect of U1 snRNP on polyadenylation of other pre-mRNAs, were shown not to be required for cleavage inhibition. Therefore, U1 snRNP bound to a 5' splice site can inhibit cleavage and polyadenylation in two mechanistically different ways depending on whether the 5' splice site is located upstream or downstream of the cleavage site.
Subject(s)
RNA Precursors/metabolism , Ribonucleoprotein, U1 Small Nuclear/metabolism , Animals , Base Sequence , Binding Sites , Bovine papillomavirus 1/genetics , Bovine papillomavirus 1/metabolism , Cattle , HIV Long Terminal Repeat , HIV-1/genetics , HIV-1/metabolism , HeLa Cells , Humans , Mutation , Polynucleotide Adenylyltransferase/metabolism , RNA Precursors/chemistry , RNA Precursors/genetics , RNA Processing, Post-Transcriptional , RNA SplicingABSTRACT
It was previously shown that the human U1A protein, one of three U1 small nuclear ribonucleoprotein-specific proteins, autoregulates its own production by binding to and inhibiting the polyadenylation of its own pre-mRNA. The U1A autoregulatory complex requires two molecules of U1A protein to cooperatively bind a 50-nucleotide polyadenylation-inhibitory element (PIE) RNA located in the U1A 3' untranslated region. Based on both biochemical and nuclear magnetic resonance structural data, it was predicted that protein-protein interactions between the N-terminal regions (amino acids [aa] 1 to 115) of the two U1A proteins would form the basis for cooperative binding to PIE RNA and for inhibition of polyadenylation. In this study, we not only experimentally confirmed these predictions but discovered some unexpected features of how the U1A autoregulatory complex functions. We found that the U1A protein homodimerizes in the yeast two-hybrid system even when its ability to bind RNA is incapacitated. U1A dimerization requires two separate regions, both located in the N-terminal 115 residues. Using both coselection and gel mobility shift assays, U1A dimerization was also observed in vitro and found to depend on the same two regions that were found in vivo. Mutation of the second homodimerization region (aa 103 to 115) also resulted in loss of inhibition of polyadenylation and loss of cooperative binding of two U1A protein molecules to PIE RNA. This same mutation had no effect on the binding of one U1A protein molecule to PIE RNA. A peptide containing two copies of aa 103 to 115 is a potent inhibitor of polyadenylation. Based on these data, a model of the U1A autoregulatory complex is presented.
Subject(s)
Ribonucleoprotein, U1 Small Nuclear/metabolism , Amino Acid Sequence , Binding Sites/genetics , Dimerization , Humans , Molecular Sequence Data , Mutation , Protein Binding , RNA/metabolism , RNA-Binding Proteins/genetics , RNA-Binding Proteins/metabolism , Ribonucleoprotein, U1 Small Nuclear/genetics , Saccharomyces cerevisiae , Sequence AlignmentABSTRACT
OBJECTIVES: This study sought to develop a methodology for estimating potential solid organ donors and measuring donation performance in a geographic region based on readily available data on the hospitals in that region. METHODS: Medical records were reviewed in a stratified random sample of 89 hospitals from 3 regions to attain a baseline of donor potential. Data on a range of hospital characteristics were collected and tested as predictors of donor potential through the use of hierarchical Poisson regression modeling. RESULTS: Five hospital characteristics predicted donor potential: hospital deaths, hospital Medicare case-mix index, total hospital staffed beds, medical school affiliation, and trauma center certification. Regional estimates were attained by aggregating individual hospital estimates. Confidence intervals for these regional estimates indicated that actual donations represented from 28% to 44% of the potential in the regions studied. CONCLUSIONS: This methodology accurately estimates organ donor potential within 3 geographic regions and lays the foundation for evaluating organ donation effectiveness nationwide. Additional research is needed to test the validity of the model in other geographic regions and to further explore organ donor potential in hospitals with fewer than 50 beds.
Subject(s)
Data Interpretation, Statistical , Medical Records/statistics & numerical data , Regional Medical Programs/statistics & numerical data , Tissue Donors/statistics & numerical data , Tissue and Organ Procurement/statistics & numerical data , California , Diagnosis-Related Groups/statistics & numerical data , Hospital Bed Capacity/statistics & numerical data , Hospital Mortality , Hospitals, Teaching/statistics & numerical data , Humans , Midwestern United States , Predictive Value of Tests , Regression Analysis , Reproducibility of Results , Trauma Centers/statistics & numerical data , WashingtonABSTRACT
It has previously been shown in vivo that bovine papillomavirus represses its late gene expression via a 5' splice site sequence located upstream of the late polyadenylation signal. Here, the mechanism of repression is determined by in vitro analysis. U1 snRNP binding to the 5' splice site results in inhibition of polyadenylation via a direct interaction with poly(A) polymerase (PAP). Although the inhibitory mechanism is similar to that used in U1A autoregulation, U1A within the U1 snRNP does not contribute to PAP inhibition. Instead the U1 70K protein, when bound to U1 snRNA, both interacts with and inhibits PAP. Conservation of the U1 70K inhibitory domains suggests that polyadenylation regulation via PAP inhibition may be more widespread than previously thought.
Subject(s)
Bacterial Proteins/metabolism , Escherichia coli Proteins , Gene Expression Regulation, Enzymologic , Polynucleotide Adenylyltransferase , RNA Precursors/metabolism , Ribonucleoprotein, U1 Small Nuclear/metabolism , Saccharomyces cerevisiae Proteins , Adenine/metabolism , Amino Acid Sequence , Animals , Bacterial Proteins/genetics , Cattle , Cell Nucleus/chemistry , Cell Nucleus/enzymology , Enzyme Activation/physiology , HeLa Cells , Humans , Molecular Sequence Data , RNA Precursors/genetics , RNA Splicing/physiology , Ribonuclease H , Ribonucleoprotein, U1 Small Nuclear/genetics , Saccharomyces cerevisiae/chemistry , Saccharomyces cerevisiae/enzymologyABSTRACT
In this article the results of a 2-year intervention designed to increase rates of organ donation while improving services to bereaved families of potential donors are described. The project focused on improving key elements of the organ donation process. The intervention was implemented in 50 hospitals within the service areas of three organ procurement organizations. Results show an increase in identification, referral, and asking rates. The overall donation rate increased significantly, from 33% to 43%. However, consent rates remained unchanged. Future efforts should focus on improving the request process by systematically incorporating practices that are associated with higher consent rates. This should enable hospital and organ procurement organization staff to appropriately and effectively offer families the option of organ donation; further increases in organ donation should follow.
Subject(s)
Family/psychology , Hospital Administration , Informed Consent , Tissue Donors/supply & distribution , Tissue and Organ Procurement/organization & administration , Bereavement , Humans , Program Evaluation , Referral and ConsultationABSTRACT
Interactions required for inhibition of poly(A) polymerase (PAP) by the U1 snRNP-specific U1A protein, a reaction whose function is to autoregulate U1A protein production, are examined. PAP inhibition requires a substrate RNA to which at least two molecules of U1A protein can bind tightly, but we demonstrate that the secondary structure of the RNA is not highly constrained. A mutational analysis reveals that the carboxy-terminal 20 amino acids of PAP are essential for its inhibition by the U1A-RNA complex. Remarkably, transfer of these amino acids to yeast PAP, which is otherwise not affected by U1A protein, is sufficient to confer U1A-mediated inhibition onto the yeast enzyme. A glutathione S-transferase fusion protein containing only these 20 PAP residues can interact in vitro with an RNA-U1A protein complex containing two U1A molecules, but not with one containing a single U1A protein, explaining the requirement for two U1A-binding sites on the autoregulatory RNA element. A mutational analysis of the U1A protein demonstrates that amino acids 103-119 are required for PAP inhibition. A monomeric synthetic peptide consisting of the conserved U1A amino acids from this region has no detectable effect on PAP activity. However, the same U1A peptide, when conjugated to BSA, inhibits vertebrate PAP. In addition to this activity, the U1A peptide-BSA conjugate specifically uncouples splicing and 3'-end formation in vitro without affecting uncoupled splicing or 3'-end cleavage efficiencies. This suggests that the carboxy-terminal region of PAP with which it interacts is involved not only in U1A autoregulation but also in the coupling of splicing and 3'-end formation.
Subject(s)
Polynucleotide Adenylyltransferase/metabolism , RNA-Binding Proteins/metabolism , Ribonucleoprotein, U1 Small Nuclear/metabolism , Amino Acid Sequence , Animals , Base Sequence , Binding Sites/genetics , Cattle , Conserved Sequence , Fungal Proteins/chemistry , Fungal Proteins/genetics , Fungal Proteins/metabolism , Homeostasis , Humans , Molecular Sequence Data , Nucleic Acid Conformation , Polynucleotide Adenylyltransferase/chemistry , Polynucleotide Adenylyltransferase/genetics , RNA/chemistry , RNA/genetics , RNA/metabolism , RNA Splicing , RNA-Binding Proteins/chemistry , RNA-Binding Proteins/genetics , Recombinant Fusion Proteins/chemistry , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism , Ribonucleoprotein, U1 Small Nuclear/chemistry , Ribonucleoprotein, U1 Small Nuclear/genetics , Species SpecificitySubject(s)
Hospitals/classification , Tissue and Organ Procurement/organization & administration , Chi-Square Distribution , Hospital Bed Capacity , Humans , Informed Consent , Medical Records , Random Allocation , Reproducibility of Results , Retrospective Studies , Tissue Donors , Transplantation , Trauma Centers , United StatesABSTRACT
The plant and vertebrate snRP proteins U1A and U2B' are structurally closely related, but bind to different U snRNAs. Two additional related snRNP proteins, the yeast U2B' protein and Drosophila SNF/D25 protein, are analyzed here. We show that the previously described yeast open reading frame YIB9w encodes yeast U2B' as judged by the fact that the protein encoded by YIB9w bindsto stem-loop IV of yeast U2 snRNA in vitro and is part of the U2 snRNP in vivo. In contrast to the human U2B' protein, specific binding of yeast U2B' to RNA in vitro can occur in the absence of an accessory U2A' protein. The Drosophila SNF-D25 protein, unlike all other U1A/U2B' proteins studied to date, is shown to be a component of both U1 and U2 snRNPs. In vitro, SNF/D25 binds to U1 snRNA on itsown and to U2 snRNA in the presence of either the human U2A' protein or of Drosophila nuclear extract. Thus, its RNA-binding properties are the sum of those exhibited by human or potato U1A and U2B' proteins. Implications for the role of SNF/D25 in alternative splicing, and for the evolution of the U1A/U2B' protein family, are discussed.
Subject(s)
RNA-Binding Proteins/genetics , Ribonucleoprotein, U1 Small Nuclear/genetics , Ribonucleoprotein, U2 Small Nuclear/genetics , Amino Acid Sequence , Animals , Base Sequence , Cloning, Molecular , Drosophila , Evolution, Molecular , Humans , Molecular Sequence Data , Recombinant Proteins/genetics , Saccharomyces cerevisiae , Sequence Alignment , Solanum tuberosumABSTRACT
The 5' cap structure of RNA polymerase II transcripts and the poly(A) tail found at the 3' end of most mRNAs have been demonstrated to play multiple roles in gene expression and its regulation. In the first part of this review we will concentrate on the role played by the cap in pre-mRNA splicing and how it may contribute to efficient and specific substrate recognition. In the second half, we will discuss the roles that polyadenylation has been demonstrated to play in RNA metabolism and will concentrate in particular on an elegant mechanism where regulation of polyadenylation is used to control gene expression.
Subject(s)
RNA Caps/physiology , RNA Precursors/metabolism , RNA Processing, Post-Transcriptional/genetics , Animals , Gene Expression Regulation , Humans , Poly A , RNA Precursors/genetics , RNA Splicing/genetics , RNA-Binding Proteins/metabolism , Ribonucleoprotein, U1 Small Nuclear/metabolismABSTRACT
The human U1 snRNP-specific U1A protein autoregulates its production by binding its own pre-mRNA and inhibiting polyadenylation. The mechanism of this regulation has been elucidated by in vitro studies. U1A protein is shown not to prevent either binding of cleavage and polyadenylation specificity factor (CPSF) to its recognition sequence (AUUAAA) or to prevent cleavage of U1A pre-mRNA. Instead, U1A protein bound to U1A pre-mRNA inhibits both specific and nonspecific polyadenylation by mammalian, but not by yeast, poly(A) polymerase (PAP). Domains are identified in both proteins whose removal uncouples the polyadenylation activity of mammalian PAP from its inhibition via RNA-bound U1A protein. Finally, U1A protein is shown to specifically interact with mammalian PAP in vitro. The possibility that this interaction may reflect a broader role of the U1A protein in polyadenylation is discussed.